Vasopressin marker copeptin and the development of renal and metabolic disorders in patients with type 2 diabetes
Abstract. The aim of the study was to evaluate the possibility of using copeptin as a marker of renal and metabolic dysfunction in patients with type 2 diabetes. Methods: In this cross-sectional, observational study included 78 patients with type 2 diabetes mellitus complicated by diabetic nephr...
Main Authors: | , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
State Institution «Institute of Nephrology NAMS of Ukraine"
2022-06-01
|
Series: | Український Журнал Нефрології та Діалізу |
Subjects: | |
Online Access: | https://ukrjnd.com.ua/index.php/journal/article/view/646 |